Prevalence of cutaneous warts in patients with systemic lupus erythematosus: a systematic review

被引:3
作者
Silva, Luisa Moreira [1 ]
Dourado Santos, Willer Goncalves [1 ]
Santiago, Mittermayer Barreto [1 ,2 ]
机构
[1] Escola Bahiana Med Saude Publ, Salvador, BA, Brazil
[2] Serv Especializados Reumatol Bahia, Rua Conde Filho 117, BR-40150150 Salvador, BA, Brazil
关键词
Cutaneous warts; Systemic lupus erythematosus; Immunosuppressive drugs; HPV; Human Papillomavirus; HUMAN-PAPILLOMAVIRUS INFECTION; VIRAL-INFECTIONS; ANTIBODIES; DIAGNOSIS; LESIONS;
D O I
10.3855/jidc.7947
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to review and evaluate systematically the scientific evidence on the relationship between systemic lupus erythematosus (SLE) and cutaneous warts (CW) caused by human papillomavirus (HPV) infection. With strict inclusion and exclusion criteria, we extensively searched the PUBMED, BVS (Virtual Health Library), and SCOPUS databases for the studies that evaluated the prevalence of CW in patients with SLE. Secondary references were additionally obtained from the selected articles. Only four articles met the research criteria and showed a higher frequency of CW in SLE patients compared to healthy controls. One of them highlighted about rheumatoid factor (RF) in the sera of patients with SLE and found an inverse correlation between the occurrence of warts and RF autoantibody. Moreover, most of the selected articles showed that the presence of CW did not correlate with the use of immunosuppressive drugs. Therefore, these findings suggest that the prevalence of CW in patients with SLE is probably high due to the defects in immune mechanisms, independently of immunosuppressive drugs.
引用
收藏
页码:902 / 906
页数:5
相关论文
共 20 条
[11]   Cutaneous papillomavirus infection in patients with rheumatoid arthritis or systemic lupus erythematosus. A case-control study [J].
Martinez-Martinez, M. U. ;
Baranda-Candido, L. ;
Abud-Mendoza, C. .
LUPUS, 2013, 22 (09) :948-952
[12]  
Piaserico S, 2014, GIORN ITAL DERMAT V, V149, P409
[13]   HPV Carcinomas in Immunocompromised Patients [J].
Reusser, Nicole M. ;
Downing, Christopher ;
Guidry, Jacqueline ;
Tyring, Stephen K. .
JOURNAL OF CLINICAL MEDICINE, 2015, 4 (02) :260-281
[14]   Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review [J].
Santana, Iuri Useda ;
Gomes, Alline do Nascimento ;
Lyrio, Leomar D'Cirqueira ;
Rios Grassi, Maria Fernanda ;
Santiago, Mittermayer Barreto .
CLINICAL RHEUMATOLOGY, 2011, 30 (05) :665-672
[15]  
Sulowicz J, 2013, POL ARCH MED WEWN, V123, P686
[16]   Neutralization-enhancing RF antibodies for HIV vaccines [J].
Suslov, Konstantin V. .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[17]  
Swygart C, 1997, BRIT J BIOMED SCI, V54, P299
[18]   Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus [J].
Tam, LS ;
Chan, AYK ;
Chan, PKS ;
Chang, AR ;
Li, EK .
ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3619-3625
[19]  
Tschandl P, 2014, CURR PROBL DERMATOL, V45, P92, DOI 10.1159/000355966
[20]  
YELL JA, 1993, LUPUS, V2, P21, DOI 10.1177/096120339300200105